17th Dec 2021 11:13
Arix Bioscience PLC Arix Bioscience PLC: Director/PDMR Shareholdings 17-Dec-2021 / 11:12 GMT/BST
Arix Bioscience plc Director/PDMR Shareholdings Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them | 1 | Details of the person discharging managerial responsibilities / person closely associated | | a) | Name | Robert Lyne | | 2 | Reason for the notification | | a) | Position/status | CEO and General Counsel | | b) | Initial notification /Amendment | Initial Notification | | 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | | a) | Name | Arix Bioscience plc | | b) | LEI | 213800OVT3AHQCXNIX43 | | 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | | a) | Description of the financial instrument, type of instrument | Arix Bioscience plc Ordinary shares of 0.001 pence each | | | | | Identification code | GB00BD045071 | | b) | Nature of the transaction | Share purchase | | c) | Price(s) and volume(s) | | | | | | | | Price(s) | Volume(s) | | | | | 120.00p | 41,666.00 | | | d) | Aggregated information | | | | | | - Aggregated volume | N/A single transaction | | | | | - Price | £49,999.20 | | | | | e) | Date of the transaction | 16 December 2021 | | f) | Place of the transaction | London Stock Exchange |
| 1 | Details of the person discharging managerial responsibilities / person closely associated | | a) | Name | Peregrine Moncreiffe | | 2 | Reason for the notification | | a) | Position/status | Non-Executive Director and Chair of the Board | | b) | Initial notification /Amendment | Initial Notification | | 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | | a) | Name | Arix Bioscience plc | | b) | LEI | 213800OVT3AHQCXNIX43 | | 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | | a) | Description of the financial instrument, type of instrument | Arix Bioscience plc Ordinary shares of 0.001 pence each | | | | | Identification code | GB00BD045071 | | b) | Nature of the transaction | Share purchase | | c) | Price(s) and volume(s) | | | | | | | | Price(s) | Volume(s) | | | | | 119.00p | 84,000.00 | | | d) | Aggregated information | | | | | | - Aggregated volume | N/A single transaction | | | | | - Price | £99,959.98 | | | | | e) | Date of the transaction | 16 December 2021 | | f) | Place of the transaction | London Stock Exchange |
| 1 | Details of the person discharging managerial responsibilities / person closely associated | | a) | Name | Sir Michael Bunbury | | 2 | Reason for the notification | | a) | Position/status | Non-Executive Director and Senior Independent Director (SID) | | b) | Initial notification /Amendment | Initial Notification | | 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | | a) | Name | Arix Bioscience plc | | b) | LEI | 213800OVT3AHQCXNIX43 | | 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | | a) | Description of the financial instrument, type of instrument | Arix Bioscience plc Ordinary shares of 0.001 pence each | | | | | Identification code | GB00BD045071 | | b) | Nature of the transaction | Share purchase | | c) | Price(s) and volume(s) | | | | | | | | Price(s) | Volume(s) | | | | | 119.00p | 40,000.00 | | | d) | Aggregated information | | | | | | - Aggregated volume | N/A single transaction | | | | | - Price | £47,600.00 | | | | | e) | Date of the transaction | 16 December 2021 | | f) | Place of the transaction | London Stock Exchange |
For further information please contact: Derringtons Limited, Company Secretary+44 20 8819 6486 Ends.
Dissemination of a CORPORATE NEWS, transmitted by EQS Group.The issuer is solely responsible for the content of this announcement.
|
End of Announcement - EQS News Service
1259488 17-Dec-2021
corporate announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.
Related Shares:
ARIX.L
